Sales & Marketing The Pandemic Treaty and the opportunity to end ‘vaccine apar... Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid.
Patients Empowering rare disease patient advocacy organisations with ... Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare dis
Patients What does the future of European healthcare look like? After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term?
Patients Sponsored The invisible burden of RSV on older adults As we continue to move beyond the COVID-19 pandemic, we’ve seen many aspects of life returning to normal.
Patients Company profile ZS Associates ZS Associates is transforming global healthcare by driving toward a connected ecosystem.
Patients Inside the pharmaceutical greenhouse For centuries, millions of people around the world have turned to the plants and trees around them to develop herbal and traditional remedies.
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.